Pyrazolone derivative C29 protects against HFD-induced obesity in mice via activation of AMPK in adipose tissue
文献类型:期刊论文
作者 | Li, Bo-han1,2; Zhang, Mei1![]() ![]() ![]() ![]() |
刊名 | ACTA PHARMACOLOGICA SINICA
![]() |
出版日期 | 2020-09-15 |
页码 | 11 |
关键词 | AMP-activated protein kinase pyrazolone derivative C29 obesity energy expenditure thermogenesis inguinal white adipose tissue white adipose browning |
ISSN号 | 1671-4083 |
DOI | 10.1038/s41401-020-00524-0 |
通讯作者 | Nan, Fa-jun(fjnan@simm.ac.cn) ; Li, Jing-ya(jyli@simm.ac.cn) |
英文摘要 | Beige adipocytes have been considered as a potential strategy in anti-obesity therapy because of its thermogenic capacity. AMP-activated protein kinase (AMPK) plays important roles in regulating adipose tissue function. C29 is a novel pyrazolone derivative with AMPK activity. In the current study, we investigated the role of C29 in the regulation of thermogenesis using differentiated adipocytes and diet-induced obese mice, and explored the mechanisms that might be involved in energy expenditure via adipocyte AMPK activation. We showed that treatment with C29 (2.5-10 mu M) concentration-dependently increased thermogenesis in differentiated preadipocytes separated from inguinal white adipose tissue (iWAT), evidenced by increased expression levels of thermogenesis markers such asUcp1,Pgc-1 alpha,Dio2,Prdm16,Cox7a1,Cox8b,Elovl3,andCidea, fatty acid oxidation (FAO) genes includingCpt1a,LcadandPpar alpha, as well as beige-selective genes such asCd137,Tmem26,Slc27a1,andTbx1. In high-fat diet (HFD)-fed mice, oral administration of C29 (30 mg center dot kg(-1)center dot day(-1)) for 9 weeks alleviated HFD-induced obesity, promoted energy expenditure and modulated iWAT browning. However, these effects were not observed in adipose-specific AMPK alpha 1/alpha 2 knockout (AKO) mice following C29 administration. Together, this study demonstrates that C29 regulates energy balance via adipocyte AMPK. Our findings show that the discovery of AMPK activators that specifically target adipose tissue may have therapeutic potential for treating obesity-related metabolic diseases. |
WOS关键词 | BROWN-FAT ; GLUCOSE-HOMEOSTASIS ; INSULIN SENSITIVITY ; SKELETAL-MUSCLE ; ENERGY-BALANCE ; BEIGE ; THERMOGENESIS ; ADIPOCYTES ; PHOSPHORYLATION ; METABOLISM |
资助项目 | National Natural Science Foundation of China[81470166] ; National Natural Science Foundation of China[81273566] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program of China[2018ZX09711002] |
WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
语种 | 英语 |
WOS记录号 | WOS:000569557900001 |
出版者 | NATURE PUBLISHING GROUP |
源URL | [http://119.78.100.183/handle/2S10ELR8/291189] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Nan, Fa-jun; Li, Jing-ya |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Drug Screening Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China 2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
推荐引用方式 GB/T 7714 | Li, Bo-han,Zhang, Mei,Duan, Ya-nan,et al. Pyrazolone derivative C29 protects against HFD-induced obesity in mice via activation of AMPK in adipose tissue[J]. ACTA PHARMACOLOGICA SINICA,2020:11. |
APA | Li, Bo-han.,Zhang, Mei.,Duan, Ya-nan.,Shuai, Lin.,Jiang, Hao-wen.,...&Li, Jing-ya.(2020).Pyrazolone derivative C29 protects against HFD-induced obesity in mice via activation of AMPK in adipose tissue.ACTA PHARMACOLOGICA SINICA,11. |
MLA | Li, Bo-han,et al."Pyrazolone derivative C29 protects against HFD-induced obesity in mice via activation of AMPK in adipose tissue".ACTA PHARMACOLOGICA SINICA (2020):11. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。